Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Get Free Report) was upgraded by equities researchers at Barclays to a “strong sell” rating in a report released on Tuesday, Zacks.com reports.
Separately, Royal Bank of Canada upgraded Recordati Industria Chimica e Farmaceutica to a “hold” rating in a research report on Monday, October 7th.
Check Out Our Latest Report on Recordati Industria Chimica e Farmaceutica
Recordati Industria Chimica e Farmaceutica Stock Performance
Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Get Free Report) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $0.70 EPS for the quarter. Recordati Industria Chimica e Farmaceutica had a return on equity of 30.78% and a net margin of 17.41%. The company had revenue of $622.00 million during the quarter.
Recordati Industria Chimica e Farmaceutica Company Profile
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.
See Also
- Five stocks we like better than Recordati Industria Chimica e Farmaceutica
- Stock Market Sectors: What Are They and How Many Are There?
- WD-40 Company Gears Up for a Double-Digit Stock Advance
- Trading Halts Explained
- Monster and Celsius Energized: Which Stock Offers More Upside?
- How to Use the MarketBeat Dividend Calculator
- Sherwin-Williams Plunges Into Buying Opportunity: Time to Buy?
Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.